Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system agents and kinase inhibitors. Its structure allows for the introduction of fluorinated aromatic systems linked via an ether-amine chain, which is valuable in enhancing metabolic stability and binding affinity in drug candidates. Commonly employed in medicinal chemistry for optimizing lead compounds in treatments targeting neurological disorders and certain cancers. Also utilized in the preparation of selective serotonin reuptake inhibitors and related antidepressant molecules due to its ability to mimic bioactive conformations.